All this, together with the diminished levels of W-Tau in Alzheimer’s disease patients, might suggest that intronic sequences could have a modulating effect by means of generating species-specific isoforms through determined alternative splicing mechanisms such as intron retention. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.